ENTRY       D03021                      Drug
NAME        Azacitidine (JAN/USAN/INN);
            Vidaza (TN)
PRODUCT     AZACITIDINE (BluePoint Laboratories)
            ONUREG (Celgene Corporation)
            VIDAZA (Celgene Corporation)
  GENERIC   AZACITIDINE (Accord Healthcare)
            AZACITIDINE (Amneal Pharmaceuticals LLC)
            AZACITIDINE (Apotex Corp)
            AZACITIDINE (Armas Pharmaceuticals)
            AZACITIDINE (BluePoint Laboratories)
            AZACITIDINE (BluePoint Laboratories)
            AZACITIDINE (Breckenridge Pharmaceutical)
            AZACITIDINE (CELLTRION USA)
            AZACITIDINE (Cipla USA)
            AZACITIDINE (Dr. Reddy's Laboratories)
            AZACITIDINE (Dr. Reddy's Laboratories)
            AZACITIDINE (Dr. Reddy's Laboratories)
            AZACITIDINE (Dr. Reddy's Laboratories)
            AZACITIDINE (Eugia US LLC)
            AZACITIDINE (Fresenius Kabi USA)
            AZACITIDINE (Hikma Pharmaceuticals USA)
            AZACITIDINE (Meitheal Pharmaceuticals)
            AZACITIDINE (Meitheal Pharmaceuticals)
            AZACITIDINE (NorthStar RxLLC)
            AZACITIDINE (NorthStar RxLLC)
            AZACITIDINE (Panacea Biotec Limited)
            AZACITIDINE (Sandoz)
            AZACITIDINE (Sandoz)
            AZACITIDINE (Wockhardt USA LLC.)
            AZACITIDINE FOR (Cipla USA)
FORMULA     C8H12N4O5
EXACT_MASS  244.0808
MOL_WEIGHT  244.2047
REMARK      Same as: C11262
            Therapeutic category: 4291
            ATC code: L01BC07
            Product: D03021<JP/US>
EFFICACY    Antineoplastic, Antimetabolite
  DISEASE   Myelodysplastic syndrome [DS:H01481]
COMMENT     Cytidine [CPD:C00475] analog
TARGET      DNMT [HSA:1786 1788 1789] [KO:K00558 K17398 K17399]
  PATHWAY   hsa00270(1786+1788+1789)  Cysteine and methionine metabolism
            hsa05206(1786+1788+1789)  MicroRNAs in cancer
STR_MAP     map07041  Antineoplastics - antimetabolic agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BC Pyrimidine analogues
                 L01BC07 Azacitidine
                  D03021  Azacitidine (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antimetabolites
               Azacitidine
                D03021  Azacitidine (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D03021  Azacitidine (JAN/USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Methyltransferases
                DNMT
                 D03021  Azacitidine (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03021
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03021
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03021
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03021
DBLINKS     CAS: 320-67-2
            PubChem: 17397176
            ChEBI: 2038
            PDB-CCD: 5AE
            LigandBox: D03021
            NIKKAJI: J1.523G
ATOM        17
            1   C1y C    18.3340  -16.0895
            2   N4y N    19.6665  -15.6575
            3   C1y C    17.9014  -17.4167
            4   O2x O    17.1998  -15.2653
            5   C1y C    16.4982  -17.4167
            6   C1y C    16.0656  -16.0895
            7   O1a O    15.6799  -18.5506
            8   C1b C    14.7328  -15.6569
            9   O1a O    13.6982  -16.5982
            10  O1a O    18.7229  -18.5485
            11  C8x C    19.6636  -14.2586
            12  C8y C    20.8795  -16.3543
            13  N5x N    22.0894  -15.6524
            14  C8y C    22.0865  -14.2536
            15  N5x N    20.8736  -13.5567
            16  O5x O    20.8822  -17.7618
            17  N1a N    23.2968  -13.5514
BOND        18
            1     1   2 1 #Up
            2     1   3 1
            3     1   4 1
            4     3   5 1
            5     4   6 1
            6     5   7 1 #Down
            7     6   8 1 #Up
            8     8   9 1
            9     5   6 1
            10    3  10 1 #Down
            11    2  11 1
            12    2  12 1
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16   11  15 2
            17   12  16 2
            18   14  17 1
///
